25.76
-0.92
(-3.45%)
At close: April 16 at 4:00:00 PM EDT
25.99
+0.23
+(0.89%)
Pre-Market: 8:57:32 AM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BOYCE SARAH Chief Executive Officer | Sale | Mar 20, 2025 | 305,871 |
| CALDERARO CHARLES III Chief Technology Officer | Stock Award(Grant) | Jan 6, 2025 | 40,000 |
| FLANAGAN WILLIAM MICHAEL Officer | Sale | Mar 20, 2025 | 80,195 |
| HUGHES STEVEN GEORGE Officer | Sale | Mar 20, 2025 | 72,850 |
| LEVIN ARTHUR A. Director | Sale | Jan 21, 2025 | 144,330 |
| MACLEAN MICHAEL F. Chief Financial Officer | Sale | Mar 20, 2025 | 96,720 |
| MCCARTHY TERESA Officer | Sale | Mar 20, 2025 | 97,130 |
| MORIARTY JOHN B Officer | Stock Award(Grant) | Jan 6, 2025 | 50,000 |
| MOSBROOKER ERIC B. Officer | Stock Award(Grant) | Jan 6, 2025 | 61,120 |
| THOMPSON TAMAR Director | Sale | Oct 7, 2024 | -- |
Related Tickers
DYN Dyne Therapeutics, Inc.
7.83
-0.25%
SRRK Scholar Rock Holding Corporation
29.76
-1.52%
CYTK Cytokinetics, Incorporated
39.15
+1.53%
CRNX Crinetics Pharmaceuticals, Inc.
29.58
-0.27%
EWTX Edgewise Therapeutics, Inc.
13.03
+0.08%
PTGX Protagonist Therapeutics, Inc.
45.80
-2.45%
NUVL Nuvalent, Inc.
69.97
-1.14%
STOK Stoke Therapeutics, Inc.
7.56
-2.45%
BBIO BridgeBio Pharma, Inc.
33.85
-1.14%
VERA Vera Therapeutics, Inc.
21.24
-1.62%